pubmed-article:8307892 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8307892 | lifeskim:mentions | umls-concept:C0024109 | lld:lifeskim |
pubmed-article:8307892 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
pubmed-article:8307892 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8307892 | lifeskim:mentions | umls-concept:C0162336 | lld:lifeskim |
pubmed-article:8307892 | lifeskim:mentions | umls-concept:C0205214 | lld:lifeskim |
pubmed-article:8307892 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:8307892 | pubmed:dateCreated | 1994-3-17 | lld:pubmed |
pubmed-article:8307892 | pubmed:abstractText | The effect of papaverine on the albumin permeability-surface area product (PS), reflection coefficient (sigma), and capillary filtration coefficient (Kf) was examined in isolated rabbit lungs. Because PS and Kf are functions of vascular surface area and permeability, we also compared papaverine with two other means of maximizing lung surface area: isoproterenol (1 x 10(-7) M) and a mild increase in vascular pressure. Only lungs perfused with 0.1 mg/ml papaverine were significantly different from control. PS increased from control (2.80 +/- 0.16 to 5.53 +/- 0.20 ml.min-1.g dry lung-1 x 10(-2), whereas sigma decreased from control (0.92 +/- 0.01 to 0.78 +/- 0.03). Kf after papaverine was significantly lower than baseline predrug Kf (5.60 +/- 0.78 to 4.56 +/- 0.53 ml.s-1.cmH2O-1.g dry lung-1 x 10(-3). However, this group's predrug Kf was higher than that of any other group. Our results indicate that papaverine increases albumin permeability and decreases endothelial selectivity. The isolated perfused lung appears fully recruited, because Kf and PS did not increase with isoproterenol or increased vascular pressure. Papaverine should be used with caution in the Ringer-perfused lung. | lld:pubmed |
pubmed-article:8307892 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8307892 | pubmed:language | eng | lld:pubmed |
pubmed-article:8307892 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8307892 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8307892 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8307892 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8307892 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8307892 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8307892 | pubmed:month | Nov | lld:pubmed |
pubmed-article:8307892 | pubmed:issn | 8750-7587 | lld:pubmed |
pubmed-article:8307892 | pubmed:author | pubmed-author:SwansonJ AJA | lld:pubmed |
pubmed-article:8307892 | pubmed:author | pubmed-author:KernD FDF | lld:pubmed |
pubmed-article:8307892 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8307892 | pubmed:volume | 75 | lld:pubmed |
pubmed-article:8307892 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8307892 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8307892 | pubmed:pagination | 2326-31 | lld:pubmed |
pubmed-article:8307892 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:meshHeading | pubmed-meshheading:8307892-... | lld:pubmed |
pubmed-article:8307892 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8307892 | pubmed:articleTitle | Effect of common vasodilators on lung microvascular permeability. | lld:pubmed |
pubmed-article:8307892 | pubmed:affiliation | Department of Physiology, James H. Quillen College of Medicine, Johnson City, Tennessee 37614-0576. | lld:pubmed |
pubmed-article:8307892 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8307892 | pubmed:publicationType | In Vitro | lld:pubmed |
pubmed-article:8307892 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |